Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 127

Similar articles for PubMed (Select 23399562)

1.

Fenofibrate down-regulates the expressions of androgen receptor (AR) and AR target genes and induces oxidative stress in the prostate cancer cell line LNCaP.

Zhao H, Zhu C, Qin C, Tao T, Li J, Cheng G, Li P, Cao Q, Meng X, Ju X, Shao P, Hua L, Gu M, Yin C.

Biochem Biophys Res Commun. 2013 Mar 8;432(2):320-5. doi: 10.1016/j.bbrc.2013.01.105. Epub 2013 Feb 8.

PMID:
23399562
3.

Piperazine-designed alpha 1A/alpha 1D-adrenoceptor blocker KMUP-1 and doxazosin provide down-regulation of androgen receptor and PSA in prostatic LNCaP cells growth and specifically in xenografts.

Liu CM, Lo YC, Tai MH, Wu BN, Wu WJ, Chou YH, Chai CY, Huang CH, Chen IJ.

Prostate. 2009 May 1;69(6):610-23. doi: 10.1002/pros.20919.

PMID:
19143029
4.

Differential targeting of androgen and glucocorticoid receptors induces ER stress and apoptosis in prostate cancer cells: a novel therapeutic modality.

Yemelyanov A, Bhalla P, Yang X, Ugolkov A, Iwadate K, Karseladze A, Budunova I.

Cell Cycle. 2012 Jan 15;11(2):395-406. doi: 10.4161/cc.11.2.18945. Epub 2012 Jan 15.

5.

7-epi-nemorosone from Clusia rosea induces apoptosis, androgen receptor down-regulation and dysregulation of PSA levels in LNCaP prostate carcinoma cells.

Díaz-Carballo D, Gustmann S, Acikelli AH, Bardenheuer W, Buehler H, Jastrow H, Ergun S, Strumberg D.

Phytomedicine. 2012 Nov 15;19(14):1298-306. doi: 10.1016/j.phymed.2012.08.004. Epub 2012 Sep 14.

PMID:
22981203
6.

Anti-androgen receptor signaling and prostate cancer inhibitory effects of sucrose- and benzophenone-compounds.

Wang Z, Lee HJ, Wang L, Jiang C, Baek NI, Kim SH, Lü J.

Pharm Res. 2009 May;26(5):1140-8. doi: 10.1007/s11095-009-9833-2. Epub 2009 Mar 6.

PMID:
19266268
7.

Down-Regulation of prostate-specific antigen expression by ligands for peroxisome proliferator-activated receptor gamma in human prostate cancer.

Hisatake JI, Ikezoe T, Carey M, Holden S, Tomoyasu S, Koeffler HP.

Cancer Res. 2000 Oct 1;60(19):5494-8.

8.

Sorafenib decreases proliferation and induces apoptosis of prostate cancer cells by inhibition of the androgen receptor and Akt signaling pathways.

Oh SJ, Erb HH, Hobisch A, Santer FR, Culig Z.

Endocr Relat Cancer. 2012 May 3;19(3):305-19. doi: 10.1530/ERC-11-0298. Print 2012 Jun.

9.
10.

Lovastatin causes diminished PSA secretion by inhibiting AR expression and function in LNCaP prostate cancer cells.

Yang L, Egger M, Plattner R, Klocker H, Eder IE.

Urology. 2011 Jun;77(6):1508.e1-7. doi: 10.1016/j.urology.2010.12.074. Erratum in: Urology. 2011 Oct;78(4):973.

PMID:
21624609
11.

PC-SPES: Molecular mechanism to induce apoptosis and down-regulate expression of PSA in LNCaP human prostate cancer cells.

Ikezoe T, Chen SS, Yang Y, Heber D, Taguchi H, Koeffler HP.

Int J Oncol. 2003 Nov;23(5):1461-70.

PMID:
14532991
12.

Activation of p53 signaling and inhibition of androgen receptor mediate tanshinone IIA induced G1 arrest in LNCaP prostate cancer cells.

Won SH, Lee HJ, Jeong SJ, Lü J, Kim SH.

Phytother Res. 2012 May;26(5):669-74. doi: 10.1002/ptr.3616. Epub 2011 Oct 13.

PMID:
21997969
13.

Upregulation of prostate-derived Ets factor by luteolin causes inhibition of cell proliferation and cell invasion in prostate carcinoma cells.

Tsui KH, Chung LC, Feng TH, Chang PL, Juang HH.

Int J Cancer. 2012 Jun 15;130(12):2812-23. doi: 10.1002/ijc.26284. Epub 2011 Aug 30.

PMID:
21780100
14.
15.

Exisulind and related compounds inhibit expression and function of the androgen receptor in human prostate cancer cells.

Lim JT, Piazza GA, Pamukcu R, Thompson WJ, Weinstein IB.

Clin Cancer Res. 2003 Oct 15;9(13):4972-82.

16.

GCP-mediated growth inhibition and apoptosis of prostate cancer cells via androgen receptor-dependent and -independent mechanisms.

Tepper CG, Vinall RL, Wee CB, Xue L, Shi XB, Burich R, Mack PC, de Vere White RW.

Prostate. 2007 Apr 1;67(5):521-35.

PMID:
17252539
17.
18.

Regulation of androgen receptor expression by Z-isochaihulactone mediated by the JNK signaling pathway and might be related to cytotoxicity in prostate cancer.

Liu PY, Lin SZ, Sheu JJ, Lin CT, Lin PC, Chou YW, Huang MH, Chiou TW, Harn HJ.

Prostate. 2013 Apr;73(5):531-41. doi: 10.1002/pros.22593. Epub 2012 Oct 4.

PMID:
23038474
19.

A synthetic decursin analog with increased in vivo stability suppresses androgen receptor signaling in vitro and in vivo.

Zhang Y, Shaik AA, Xing C, Chai Y, Li L, Zhang J, Zhang W, Kim SH, Lü J, Jiang C.

Invest New Drugs. 2012 Oct;30(5):1820-9. doi: 10.1007/s10637-011-9738-x. Epub 2011 Aug 26.

PMID:
21870073
20.

Effect of small molecules modulating androgen receptor (SARMs) in human prostate cancer models.

Tesei A, Leonetti C, Di Donato M, Gabucci E, Porru M, Varchi G, Guerrini A, Amadori D, Arienti C, Pignatta S, Paganelli G, Caraglia M, Castoria G, Zoli W.

PLoS One. 2013 May 8;8(5):e62657. doi: 10.1371/journal.pone.0062657. Print 2013.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk